Prof. Yossi (Joseph) Tam
Prof. Yossi (Joseph) Tam
Head, Obesity and Metabolism Laboratory, The Hebrew University of Jerusalem
Verified email at - Homepage
Cited by
Cited by
Peripheral cannabinoid receptor, CB2, regulates bone mass
O Ofek, M Karsak, N Leclerc, M Fogel, B Frenkel, K Wright, J Tam, ...
Proceedings of the National Academy of Sciences 103 (3), 696-701, 2006
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
J Tam, VK Vemuri, J Liu, S Bátkai, B Mukhopadhyay, G Godlewski, ...
The Journal of clinical investigation 120 (8), 2953-2966, 2010
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
T Jourdan, G Godlewski, R Cinar, A Bertola, G Szanda, J Liu, J Tam, ...
Nature medicine 19 (9), 1132-1140, 2013
Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance
J Tam, R Cinar, J Liu, G Godlewski, D Wesley, T Jourdan, G Szanda, ...
Cell metabolism 16 (2), 167-179, 2012
Depression induces bone loss through stimulation of the sympathetic nervous system
R Yirmiya, I Goshen, A Bajayo, T Kreisel, S Feldman, J Tam, V Trembovler, ...
Proceedings of the National Academy of Sciences 103 (45), 16876-16881, 2006
Endocannabinoids in liver disease
J Tam, J Liu, B Mukhopadhyay, R Cinar, G Godlewski, G Kunos
Hepatology 53 (1), 346-355, 2011
The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling
J Tam, V Trembovler, V Di Marzo, S Petrosino, G Leo, A Alexandrovich, ...
The FASEB journal 22 (1), 285-294, 2008
Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling
J Tam, O Ofek, E Fride, C Ledent, Y Gabet, R Müller, A Zimmer, K Mackie, ...
Molecular pharmacology 70 (3), 786-792, 2006
Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice
J Liu, L Zhou, K Xiong, G Godlewski, B Mukhopadhyay, J Tam, S Yin, ...
Gastroenterology 142 (5), 1218-1228. e1, 2012
Endocannabinoids and the regulation of bone metabolism
I Bab, O Ofek, J Tam, J Rehnelt, A Zimmer
Journal of neuroendocrinology 20, 69-74, 2008
Hepatic cannabinoid‐1 receptors mediate diet‐induced insulin resistance by increasing de novo synthesis of long‐chain ceramides
R Cinar, G Godlewski, J Liu, J Tam, T Jourdan, B Mukhopadhyay, ...
Hepatology 59 (1), 143-153, 2014
The case for peripheral CB1 receptor blockade in the treatment of visceral obesity and its cardiometabolic complications
G Kunos, J Tam
British journal of pharmacology 163 (7), 1423-1431, 2011
Mitochondrial biogenesis and increased uncoupling protein 1 in brown adipose tissue of mice fed a ketone ester diet
S Srivastava, Y Kashiwaya, MT King, U Baxa, J Tam, G Niu, X Chen, ...
The FASEB Journal 26 (6), 2351-2362, 2012
Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects
G Godlewski, SO Alapafuja, S Bátkai, SP Nikas, R Cinar, L Offertáler, ...
Chemistry & biology 17 (11), 1256-1266, 2010
Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver
B Mukhopadhyay, R Cinar, S Yin, J Liu, J Tam, G Godlewski, ...
Proceedings of the National Academy of Sciences 108 (15), 6323-6328, 2011
Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy
T Jourdan, G Szanda, AZ Rosenberg, J Tam, BJ Earley, G Godlewski, ...
Proceedings of the National Academy of Sciences 111 (50), E5420-E5428, 2014
Muscleblind-like 1 (Mbnl1) promotes insulin receptor exon 11 inclusion via binding to a downstream evolutionarily conserved intronic enhancer
S Sen, I Talukdar, Y Liu, J Tam, S Reddy, NJG Webster
Journal of Biological Chemistry 285 (33), 25426-25437, 2010
Oleoyl serine, an endogenous N-acyl amide, modulates bone remodeling and mass
R Smoum, A Bar, B Tan, G Milman, M Attar-Namdar, O Ofek, JM Stuart, ...
Proceedings of the National Academy of Sciences 107 (41), 17710-17715, 2010
Glucocorticoid receptor dimerization is required for proper recovery of LPS-induced inflammation, sickness behavior and metabolism in mice
MN Silverman, P Mukhopadhyay, E Belyavskaya, LH Tonelli, BD Revenis, ...
Molecular psychiatry 18 (9), 1006-1017, 2013
Lef1 haploinsufficient mice display a low turnover and low bone mass phenotype in a gender-and age-specific manner
T Noh, Y Gabet, J Cogan, Y Shi, A Tank, T Sasaki, B Criswell, A Dixon, ...
PLoS One 4 (5), e5438, 2009
The system can't perform the operation now. Try again later.
Articles 1–20